What is measles?
What causes measles?
Who gets measles?
How does the measles virus cause disease?
What are the common findings?
How is measles diagnosed?
How is measles treated?
What are the complications?
How can measles be prevented?
What research is being done?
by Hal B. Jenson, M.D.
Chief, Pediatric Infectious Diseases
University of Texas Health Science Center
San Antonio, TX
by Charles T. Leach, M.D.
Associate Professor of Pediatrics
University of Texas Health Science Center
San Antonio, TX
Measles, also commonly known as "rubeola," is a viral infection that is characterized
primarily by a fever, a cough, a runny nose, red eyes, a rash, and spots inside
The measles virus, an RNA virus of the paramyxovirus family of viruses, causes measles.
Measles was an important disease that occurred in almost all children before the
introduction of the measles vaccine. Measles is highly contagious, and, historically,
it has caused large outbreaks. Prior to the use of the measles vaccine, which was
introduced in 1963, more than 500,000 cases of measles were reported each year in
the United States. The disease is now very uncommon. In 1998, only approximately
100 cases were reported in the United States.
Today, measles is usually seen only in those persons who have not received the vaccine,
typically, in children one to four years of age. Most cases in the United States
have occurred in inner city or isolated rural areas, where poverty is common and
access to health care, including measles vaccination, is difficult, or in persons
traveling to or visiting from other countries.
The measles virus is transmitted from person-to-person by direct contact or by contaminated
secretions of the nose and the mouth. The measles virus infects the lining of the
nose and the upper respiratory tract. Then, it is spread through the blood throughout
the body, which causes the rash. In the lungs, the measles virus infection can cause
pneumonia, which can be severe and life threatening, especially in infants.
Measles can be divided into four phases: 1) the incubation phase, 2) the prodromal
(catarrhal) phase, 3) the rash phase, and 4) the recovery phase.
The incubation phase typically lasts 8 to 12 days after exposure to the virus and
does not have any symptoms. The prodromal phase begins at the onset of the first
symptoms, which begin gradually and include a fever, a cough, a runny nose, and
red eyes. Usually, the fever is the first symptom noticed by parents. The fever
rises steadily and may reach maximum temperatures of 103F to 104F. At the height
of the fever, the rash develops.
The runny nose with a profuse watery discharge, nasal congestion, and sneezing becomes
prominent. Typically, there is a pronounced cough, which is hoarse, dry, and hacking.
Some children may complain of tightening in the chest. The red eyes are characterized
by increased tearing, eye pain that may be severe, and sensitivity to light. Other
symptoms that are frequently observed during the prodromal phase include fatigue,
irritability, a decreased appetite, a headache, abdominal pain, and a dry mouth
Approximately two to four days after the onset of the symptoms, the rash appears,
marking the beginning of the rash phase. The symptoms of the prodromal phase worsen
with the onset of the rash, but then begin to decrease in severity. The measles
rash is a flat or slightly raised rash, and is not itchy. It first appears as irregular
spots on the upper forehead or behind the ears and on the neck. Within 24 hours,
it progresses to the entire face, head, and neck. Over the next two to four days,
the rash extends to the chest, back, and extremities, including the palms of the
hands and the soles of the feet. It remains most prominent on the face, especially
on the cheeks.
After four to five days, the rash begins to subside, marking the beginning of the
recovery phase. Sometimes, a very fine flaking of the skin is noted as the rash
fades. About 10 to 14 days after developing the rash, the child is back to a normal
level of activity.
One of the characteristic findings of measles is the presence of spots, known as
"Koplik spots," inside the mouth. These tiny pinpoint blue-white spots begin as
a few lesions on the inside of the cheeks, typically occurring 1 to 2 days before
the rash, and increase rapidly in number over the next 24 hours. They begin to fade
as the rash appears, and usually disappear by the second day of the rash.
Measles is diagnosed primarily on the clinical and physical examination findings.
The appearance of the rash is characteristic, and when found in association with
Koplik spots inside the mouth, an experienced physician can diagnose measles. There
also is a specific antibody blood test that can be used to confirm the diagnosis.
There is no specific treatment for measles. Antibiotics are not helpful because
a virus causes measles. Viruses cannot be treated with antibiotics. The disease
is usually mild with complete recovery. Some children, especially infants and young
children, require hospitalization for intravenous fluids and occasionally because
of severe pneumonia. The fever should be treated with acetaminophen or ibuprofen.
Severe measles has been associated with very low levels of vitamin A. In developing
countries, vitamin A supplements appear to improve the course of measles, especially
in children younger than two years of age. In the United States, the American Academy
of Pediatrics recommends vitamin A supplements for certain children with measles
who are not already receiving additional daily vitamin A. Children who might need
additional vitamin A include those with:
For these children, a single dose of vitamin A (100,000 IU for infants, 6 months
to 1 year of age; 200,000 IU for older children) is given at the time that measles
is diagnosed. Excess vitamin A can be dangerous for the developing fetus of pregnant
The most frequent complications of measles are diarrhea, middle ear infection ("bacterial
otitis media"), bacterial pneumonia, and inflammation of the brain ("encephalitis").
Diarrhea is the most common complication of measles in the United States, and it
occurs in approximately 10% of children who develop measles. The diarrhea usually
begins after the rash appears, lasts for only a few days, and usually does not require
hospitalization for intravenous fluids. Otitis media occurs in approximately 5%
to 15% of children with measles, and usually begins during the second week of illness
after the rash has faded.
Pneumonia is one of the most serious complications of measles, and it can be caused
either by the measles virus itself or by bacteria that cause additional infection
during the course of measles. Children who have an immunodeficiency are at a particularly
high risk for pneumonia with measles.
Acute encephalitis (inflammation of the brain) is an uncommon complication of measles
and occurs in approximately 1 to 2 of every 1,000 cases of measles. It is a more
serious complication because it can be very severe and can lead to death.
Subacute sclerosing panencephalitis (SSPE) is a very rare, but fatal, form of degenerative
encephalitis (inflammation of the brain) that develops an average of 8 to 10 years
after a typical case of measles. SSPE occurs in approximately one out of every one
million persons with measles. The onset is usually very gradual, but results in
behavioral changes and impairment of intellectual function, leading to seizures,
coma, and death in a few years. Patients with SSPE are not contagious. SSPE has
been very uncommon in the United States since the initiation of the routine measles
Measles is effectively prevented by the routine administration of the measles vaccine,
usually given as Measles-Mumps-Rubella (MMR) vaccines to all children. This vaccine
is recommended beginning at 12 months of age. A single dose of the measles vaccine
results in protection of approximately 95% of children. To ensure that all children
are immunized, a second dose of MMR is recommended at four to six years of age;
however, it can be given to children at any age as soon as one month after the first
Many states require two doses of the measles vaccine for school entry, and many
colleges and universities require evidence of two doses of the measles vaccine for
admission. It is not a problem if an additional dose of the measles vaccine is given
in addition to the two recommended doses.
The spread of measles can be prevented by minimizing exposure to children who have
symptoms of the disease, and by good handwashing after exposure to the disease.
Because measles is now extremely uncommon, and because the vaccine is extremely
safe and effective in preventing measles, there is not much research on measles
currently being conducted. There is some research being performed on the long-term
immunity of the measles vaccine to confirm that it does provide lifelong immunity.
Hal Jenson, M.D.
Dr. Jenson graduated from George Washington University School of Medicine in Washington,
He also completed a residency in pediatrics at the Rainbow Babies and Children's
Hospital of Case Western Reserve University in Cleveland, Ohio, and a fellowship
in pediatric infectious diseases and epidemiology at Yale University School of Medicine.
Dr. Jenson has an active research program on the biology of Epstein-Barr virus and
other human and non-human primate herpes viruses.
He is active in the general pediatric and infectious diseases teaching and clinical
activities of his Department and Division, is a co-editor of Nelson Textbook of
Pediatrics and of Pediatric Infectious Diseases: Principles and Practice, and authors
the book Pocket Guide to Vaccination and Prophylaxis.
Charles T. Leach, M.D.
Dr. Leach received his medical degree at the University of Utah School of Medicine
and completed his pediatrics residency as well as a fellowship in pediatric infectious
diseases at UCLA.
He is currently Associate Professor and Director of Research in the Department of
Pediatrics at the University of Texas Health Science Center at San Antonio.
Dr. Leach conducts scientific research in the areas of herpes virus infections,
pediatric AIDS, and infectious diseases among residents of the Texas-Mexico border.
Copyright 2012 Hal B. Jenson, M.D., All Rights Reserved
The information contained in these topics is not intended nor implied to be a substitute for professional medical advice, it is provided for educational purposes only. You assume full responsibility for how you choose to use this information.
Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment or discontinuing an existing treatment. Talk with your healthcare provider about any questions you may have regarding a medical condition. Nothing contained in these topics is intended to be used for medical diagnosis or treatment.
By using this website, you accept the information provided herein "AS IS." Neither RemedyConnect nor the providers of the information contained herein will have any liability to you arising out of your use of the information contained herein or make any express or implied warranty regarding the accuracy, content, completeness, reliability, or efficacy of the information contained within this website.
RemedyConnect, Inc. has created this privacy statement in order to demonstrate our firm commitment to your privacy. The following discloses our information gathering and dissemination practices for this website: http://www.remedyconnect.com.
We do not acquire any more information about website visitors than is required by law or is otherwise necessary to provide a high level of service efficiently and securely. Our site's registration form requires users to give us contact information (e.g., their name and e-mail address) and demographic information (e.g., children's birth months, but not birth dates). We use customer contact information from the registration form to (1) send the user pertinent medical and parenting information and (2) allow your local health provider lists of who is registering on that provider's site as a parent/guardian, staff member, doctor, or visitor. Users may opt-out of receiving future mailings; see the choice/opt-out section below.
We use your IP address to help diagnose problems with our server and to administer our Website. Your IP address is used to help identify you and to gather broad demographic information.
Demographic and profile data is also collected at our site. We may use this data to tailor the visitor's experience at our site, showing them content that we think they might be interested in, and displaying the content according to their preferences.
Our site may use order forms to allow users to request information, products, and services.
We will respect your doctor's right to privacy. A doctor typically does not give his/her e-mail address to the parents/guardians of patients. We will not provide the e-mail addresses of doctor(s) in the local practice to users of their site without the doctor(s)' permission. Their site is restricted to use by whomever they wish, and they may deny access to their site to one or more prior users. In unusual cases, doctors may change their private site's access code and arrange for us to e-mail the new access code to approved users.
This site contains links to other sites. RemedyConnect.com is not responsible for the privacy practices or the content of such Websites. See Disclaimers.
We will provide individually-identifiable information about website users to third parties only if we are compelled to do so by order of a duly-empowered governmental authority, we have the express permission of the visitor, or it is necessary to process transactions and provide you services from our affiliates: Live Agent Answering Service, Digital Answering Service, Medical Answering Service and Pediatric Answering Service.
This site may make chat rooms, forums, message boards, and/or news groups available to its users. Please remember that any information that is disclosed in these areas becomes public information and you should exercise caution when deciding to disclose your personal information.
This site has security measures in place to protect the loss, misuse and alteration of the information under our control. For further information regarding our security, please contact us at email@example.com. If you have any concerns regarding the security of information, please do not provide any information to RemedyConnect, Inc. until you are comfortable with our security measures.
You may correct or update your User Registration information at any time, by visiting the User Registration section and providing your personal password that you set at registration. If need be, please email us at firstname.lastname@example.org.
Our site provides users the opportunity to opt-out of receiving e-mail communications from our partners or us, except communications approved by your doctor's practice office. To so opt-out, please email us at email@example.com. To be removed as a user, please email us at the same address. If need be, you may mail requests to us at RemedyConnect, Inc., 9200 E. Mineral Avenue, Suite 100, Centennial, CO 80112. Our telephone number is 303-793-0703.
If you have any questions about this privacy statement, the practices of this site, or your dealings with this Website, you can contact us by email at firstname.lastname@example.org or by mail at our address above.